Accepted at 2:26 a.m. Nov, 01, 2023 by shmuelsash
Author: oneMedGuy
Related Note: 1472487670528
Rationale for change

Based on FA and Amboss it causes general vasodilation and decreases both preload and afterload

https://next.amboss.com/us/article/em0xeg?utm_source=navbar&utm_medium=anki&utm_campaign=anki&utm_term=milrinone&guid=zwlJScW%255D7o&aid=2602087c-5151-49c9-a3cb-1435332f5ff7&uid=us_2p9p4a#Z431442776227da3581151dd86db0ddfb

Text Text
Extra
Used in the treatment of acute HF; should not be used in severely hypotensive patients
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy


Sketchy 2
Empty field
Sketchy Extra



Watch Sacubitril-Valsartan, Milrinone, Nesiritide, Ivabradine
Picmonic
Empty field
Pixorize


Physeo




Bootcamp
Watch associated Bootcamp video - Vasodilation and Vasoconstriction : Pharmacologic Targets

Watch associated Bootcamp video - Autonomic System : Phosphodiesterase Inhibitors
OME

Additional Resources
One by one
Empty field
#AK_Step1_v12::#Pixorize::03_Pharmacology::06_Cardiovascular_Pharm::20_Milrinone #AK_Step1_v12::#USMLERx::39332.3 #AK_Step1_v12::#Bootcamp::Cardiology::07_Vasodilation_and_Vasoconstriction::04_Pharmacologic_Targets #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::01_Heart_Failure_Drugs::03_Sacubitril-Valsartan_Milrinone_Nesiritide_Ivabradine #AK_Step1_v12::#B&B::05_Cardio::06_Heart_Failure::04_Acute_Heart_Failure #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::11_Cardiac_Glycosides #AK_Step1_v12::#UWorld::COMLEX::23262 #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::01_Cardiology::01_Hemodynamics::07_Shock #AK_Step3_v12::#OME::Intern_Content::Common_Medical_Problems::CHF_1:_In_the_Clinic #AK_Step3_v12::#OME::Intern_Content::Common_Medical_Problems::CHF_2_In_the_Hospital #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::16_Digoxin #AK_Step1_v12::#Physeo::09_Pharm::10_Cardiac::07_Milrinone #AK_Step1_v12::#OME::04_Organ_Systems::01_Cardiology::01_Hemodynamics::07_Shock !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::15_Phosphodiesterase_Inhibitors #AK_Step1_v12::#AMBOSS::25aTjO #AK_Step1_v12::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::15_Phosphodiesterase_Inhibitors::PDE_3_Inhibitors::Milrinone_Inamrinone #AK_Step1_v12::^Systems::Cardio::Pharmacology #AK_Step1_v12::#FirstAid::07_Cardiovascular::05_Pharm::11_Cardiac_Glycosides::Milrinone_Inamrinone #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#SketchyPharm::02_Cardio_&_Renal::05_Retired_Lessons::01_Digoxin,_milrinone,_nesiritide_[Retired_Video] #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::02_Critical_Care::01_Shock #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::17_Phosphodiesterase_Inhibitors #AK_Step1_v12::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::15_Phosphodiesterase_Inhibitors::PDE_3_Inhibitors #AK_Step1_v12::#UWorld::Step::149 #AK_Original_Decks::Step_1::Zanki_Pharmacology